ABN 16 165 160 841 +61 (0) 3 9123 1140 | info@ampliatx.com Level 5, 90 William Street, Melbourne VIC 3000 Australia www.ampliatx.com 28 AUGUST 2026 ASX RELEASE RESULTS OF ANNUAL GENERAL MEETING Melbourne, Australia: Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF),...
Amplia Therapeutics: Results of Annual General Meeting
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Amplia Therapeutics Ltd. has released the results of its Annual General Meeting, confirming that all resolutions were carried. The resolutions included the approval of the remuneration report and the election of directors. Details of the voting outcomes for each resolution are provided in the filing.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Amplia Therapeutics Ltd. on 6ix
In the deck
Story so far
Earlier from Amplia Therapeutics
- CEO Managing Director Presentation to Annual General Meeting
- Bioshares Biotech Summit Presentation
- Amplia signs Collaboration and Supply Agreement with Lilly
- Scientific Paper Detailing Preclinical Studies of Narmafotinib in Pancreatic Cancer Now Online
- Scientific Paper Studies of narmafotinib - Pancreatic Cancer
Later from Amplia Therapeutics
- Notification regarding unquoted securities - ATX
- Amplia and ANZGOG Finalise Protocol for Ovarian Cancer Trial
- Amplia Presents at E&P Healthcare Conference 2026
- Amplia Presents at CG Drug and Device Conference 2026
- Response to ASX Price Query
Follow Amplia Therapeutics into a list and get an email when it puts out news.
Follow Amplia Therapeutics